This test kit applies to the in vitro qualitative determination of Neutralization antibodies against SARS-CoV-2 in human serum or plasma.
This manual provides step-by-step instructions for using the Elabscience E-EL-E606 ELISA kit to detect SARS-CoV-2 neutralizing antibodies in human serum or plasma. It includes details on reagent preparation, assay protocol, washing steps, substrate addition, and optical density measurement. The kit uses a competitive ELISA method with pre-coated recombinant human ACE2 and HRP-conjugated RBD fragment. Results are interpreted based on inhibition percentage calculated from OD values of samples versus negative and positive controls.
The manual also outlines storage conditions for all components, sample collection and handling protocols, and quality control requirements, including acceptable OD ranges for positive and negative controls to validate test results.
| Catalog Number | E-EL-E606 |
|---|---|
| Product Size | 24T/96T/96T*5 |
| Storage Temperature (Unopened) | 2-8℃ |
| Repeatability | CV ≤ 15% |
| Cut-off Value | < 20% |
This ELISA kit is for in vitro qualitative determination of neutralization antibodies against SARS-CoV-2 in human serum or plasma.
The test uses a competitive ELISA method where SARS-CoV-2 neutralizing antibodies in samples compete with fixed human ACE2 for binding sites on HRP-conjugated RBD fragment.
The OD of Negative Control must be greater than 1.2 and OD of Positive Control must be less than 0.4 for valid results.
Inhibition ≥ 20% indicates positive (neutralizing antibodies detected), and inhibition < 20% indicates negative (no neutralizing antibodies detected).